← Leaderboards
Louise R Howe
Weill Medical College Of Cornell Univ
$2,441,057
Attributed
$2,654,807
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $350.7K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,654,807 · 5
By mechanism
R01$1,726,815 · 1
R03$500,491 · 3
R21$427,501 · 1
Top collaborators
- Anthony M.C. Brown2 shared
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- William K. Holloman$7,564,014
- Anthony M.c. Brown$7,440,762
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorIn VitroIn VivoPreventMalignant NeoplasmsMammary GlandMammary NeoplasmsBreastTissuesRecurrencePathway InteractionsReporterEpithelial CellsMalignant Breast NeoplasmSignal TransductionColorectal CancerLigandsProteinsReceptorPremalignantNeoplasmsColorectal NeoplasmsMolecular TargetPreventive
Grant awards (13)
Lgr5, mammary tumor stem cells, and radiation therapy$186,558
R21 · FY2015 · CA
Lgr5, mammary tumor stem cells, and radiation therapy$240,943
R21 · FY2014 · CA
Isothiocyanate-Mediated Breast Cancer Prevention$81,965
R03 · FY2014 · CA · contact PI
Isothiocyanate-Mediated Breast Cancer Prevention$84,500
R03 · FY2013 · CA · contact PI
Beta-Catenin/TCF Signaling in Breast Cancer$340,155
R01 · FY2012 · CA · contact PI
Beta-Catenin/TCF Signaling in Breast Cancer$340,155
R01 · FY2011 · CA · contact PI
Beta-Catenin/TCF Signaling in Breast Cancer$350,675
R01 · FY2010 · CA · contact PI
Beta-Catenin/TCF Signaling in Breast Cancer$350,675
R01 · FY2009 · CA · contact PI
Beta-Catenin/TCF Signaling in Breast Cancer$345,155
R01 · FY2008 · CA · contact PI
Aspirin for Breast Cancer Prevention$82,026
R03 · FY2006 · CA · contact PI
Aspirin for Breast Cancer Prevention$84,000
R03 · FY2005 · CA
Combination Chemoprevention of ER-Negative Breast Cancer$84,000
R03 · FY2004 · CA
Combination Chemoprevention of ER-Negative Breast Cancer$84,000
R03 · FY2003 · CA